Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
데이터 추가 비고
원인
An anomaly has been identifed with the plan parameters workspace within eclipse treatment planning system aria radiation oncologyaria radiation therapy management and acuity. when a dose relevant parameter is changed and "do not clear mus and reference point dose" is selected the monitor units (mus) may change. this issue does not affect brachyvision.